COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores

Clinical trial NCT05239923 · COMPLETED

Trial details

NCT number: NCT05239923
Sponsor: DreamTec Research Limited
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2021-08-28
Primary completion: 2021-11-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.